Global Healthcare EDI Market By Component (Solution, Service), By Delivery Mode (On-premise & Cloud, Mobile), By Transaction Type (Claims Management, Payment Remittance, Payments, Healthcare Supply Chain), By Region, Industry Analysis, Share, Growth, Trends, and Forecast, 2021-2028

Covid-19 Impact on Global Healthcare EDI Market

Type: PDF

Status: Published

Categories: Pharma & Healthcare

Report Code : PHC214026

No. of Pages : 282

The global healthcare EDI market is expected to grow from USD 3.1 billion in 2020 to USD 5.6 billion by 2028 at a CAGR of 7.9% over the forecast period 2021-2028.

Market Overview:

The healthcare sector utilizes a technology called Electronic Data Interchange (EDI) to transmit data back and forth using standardized formats. The information is shipped electronically, manual errors are virtually eliminated, and processing becomes more efficient. Healthcare EDI software converts documents into computer-oriented language; then, it assigns transaction codes to every document. The recipient's EDI software converts the knowledge back to documents when it reaches the recipient. This market's key driving factor is majorly attributed to the event of regulations for transaction processes; the rising got to curtail healthcare costs and government support for HCIT implementation.

Market Dynamics:

Drivers:

Increasing demand to reduce healthcare costs

regulations supporting various transactions

Restraints:

High cost associated with implementation of EDI software

Outsourcing of EDI services

Key Market Players:

McKesson Corporation, Optum, Allscripts Healthcare Solutions Inc, athenahealth, Nextgen Healthcare, Cognizant Technology Corporation, SSI Group, Cerner Corporation, Comarch SA, Axway Software SA, Optum Inc, Dell Technologies Inc, Nextgen Healthcare, Synnex Corporation, Comarch, Axway Solutions, and Plexis Healthcare Systems are some of the prominent players in the global healthcare EDI market.

The market is segmented based on the below-mentioned segments:

On the Basis of Component: Revenue

o Solution

o Service

On the Basis of Delivery Mode: Revenue

o On-premise & Cloud

o Mobile

On the Basis of Transaction Type: Revenue

o Claims Management

o Payment Remittance

o Payments

o Healthcare Supply Chain

On The Basis of Region: Revenue

North America

- U.S.A
- Canada
- Mexico

Europe

- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe

Asia Pacific

- China
- Japan
- India
- SEA
- Australia
- Rest Of APAC

South America

- Brazil
- Argentina
- Rest of South America

Middle East & Africa

- South Africa
- Saudi Arabia
- UAE
- Rest of MEA

Report Description

Year Consideration
- Base year – 2020
- Historic Year-2017-2019
- Forecast year- 2021 to 2028

The global healthcare EDI market will be based on revenue and volume. The study covers the market share for segments, countries, regions, and players.

The regions evaluated for the global healthcare EDI market are Europe, North America, Asia Pacific, South America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country-level.

The report provides an in-depth pricing analysis, value chain analysis, industry road map, and micro and macro factors.

The research report further provides the attractiveness of healthcare EDI and regions based on their growth rate (CAGR), market size, and attractiveness by analyzing present and future prospects to analyze market growth and development in the future.

Also, the study focuses on market-related driving forces, restraints, potential opportunities for the market, significant developments, and advancement that serve as a key potential for investors.

The study offers an extensive evaluation of Porter's five forces analysis, SWOT analysis, and PESTEL analysis to provide data and information related to the business.

Porter's five forces model is analyzed to understand the overall competitive scenario that prevails in the market. The SWOT analysis also identifies the positive as well as the negative characteristics of market development which influences the company’s growth and development to sustain and survive in the long run. The PESTEL analysis identifies the macro (external) forces affecting the organization.

The report includes a thorough analysis of the company profiles of major companies operating in the global healthcare EDI market and a comparative evaluation based on their business overviews, product offering, geographic presence, market share, business strategy, recent developments, product development & innovations, joint ventures, partnerships, mergers & acquisitions, expansions, SWOT analysis, and key financial information. It helps in evaluating the overall competition present in the market scenario.

Request For Request Sample

To receive a sample copy of this report, please complete the form below

Full Name

Company Name

Designation/Position

Contact

Region/Country

Message

Kindly share your specific requirement (if any), so we can get back to you with a solution

TABLE OF CONTENTS
1. INTRODUCTION
1.1. OBJECTIVES OF THE STUDY
1.2. SCOPE OF THE STUDY
1.3. GEOGRAPHIC SCOPE
1.4. MARKET DEFINITION
1.5. CURRENCY CONSIDERATION
1.6. YEAR CONSIDERATION
2. RESEARCH METHODOLOGY AND ASSUMPTIONS
2.1. SECONDARY RESEARCH
2.2. PRIMARY RESEARCH
2.3. MARKET BREAKUP AND DATA TRIANGULATION
2.4. MARKET SIZE ESTIMATION
2.4.1. BOTTOM UP APPROACH
2.4.2. TOP DOWN APPROACH
2.5. ASSUMPTION
3. EXECUTIVE SUMMARY
3.1. KEY MARKET INSIGHTS
3.2. SEGMENTATION OUTLOOK
3.3. COMPANY OUTLOOK
4. PREMIUM INSIGHTS
4.1. IMPACT OF COVID-19 ON MARKET
4.2. INDUSTRY ROAD MAP
4.3. INDUSTRY TREND
4.4. INDUSTRY SWOT ANALYSIS
4.5. MARKET ATTRACTIVENESS ANALYSIS
4.5.1. MARKET ATTRACTIVENESS BY SEGMENTS
4.5.1.1. HEALTHCARE EDI MARKET ATTENTIVENESS BY COMPONENT
4.5.1.2. HEALTHCARE EDI MARKET ATTENTIVENESS BY DELIVERY MODE
4.5.1.3. HEALTHCARE EDI MARKET ATTENTIVENESS BY TRANSACTION TYPE
4.5.2. MARKET ATTRACTIVENESS BY REGION
4.5.2.1. NORTH AMERICA HEALTHCARE EDI MARKET ATTENTIVENESS BY COUNTRY
4.5.2.2. EUROPE HEALTHCARE EDI MARKET ATTENTIVENESS BY COUNTRY
4.5.2.3. ASIA PACIFIC HEALTHCARE EDI MARKET ATTENTIVENESS BY COUNTRY
4.5.2.4. SOUTH AMERICA HEALTHCARE EDI MARKET ATTENTIVENESS BY COUNTRY
4.5.2.5. MIDDLE EAST AND AFRICA HEALTHCARE EDI MARKET ATTENTIVENESS BY COUNTRY
4.6. PORTER’S FIVE FORCES ANALYSIS
4.6.1. THREAT OF NEW ENTRANTS
4.6.2. THREAT OF SUBSTITUTES
4.6.3. BARGAINING POWER OF SUPPLIERS
4.6.4. BARGAINING POWER OF BUYERS
4.6.5. INTENSITY OF COMPETITIVE RIVALRY
4.7. VALUE CHAIN ANALYSIS
4.7.1. RESEARCH & DEVELOPMENT COMPANIES
4.7.2. RAW MATERIAL/ COMPONENT SUPPLIERS
4.7.3. PRODUCT MANUFACTURERS
4.7.4. DISTRIBUTORS AND RETAILERS
4.7.5. END-USER INDUSTRIES
4.7.6. POST-SALES SERVICE PROVIDERS
4.8. FACTORS AFFECTING THE MARKET
4.8.1. MACRO FACTORS AFFECTING THE MARKET
4.8.2. MICRO FACTORS AFFECTING THE MARKET
4.8.3. PESTEL ANALYSIS
4.9. YEAR ON YEAR GROWTH RATE OF HEALTHCARE EDI
4.10. LIST OF SUPPLIERS
4.11. LIST OF BUYERS
4.12. COUNTRY LEVEL ANALYSIS
4.13. RULES AND REGULATION
5. MARKET DYNAMICS
5.1. MARKET DRIVERS
5.1.1. INCREASING DEMAND TO REDUCE HEALTHCARE COSTS
5.1.2. GOVT. REGULATIONS SUPPORTING VARIOUS TRANSACTIONS
5.2. MARKET RESTRAINTS
5.2.1. HIGH COST ASSOCIATED WITH IMPLEMENTATION OF EDI SOFTWARE
5.2.2. OUTSOURCING OF EDI SERVICES
5.3. MARKET OPPORTUNITIES
5.4. MARKET CHALLENGES
6. GLOBAL HEALTHCARE EDI MARKET INSIGHTS AND FORECAST ANALYSIS, BY COMPONENT - 2017-2028
6.1. KEY FINDINGS
6.2.
7. GLOBAL HEALTHCARE EDI MARKET INSIGHTS AND FORECAST ANALYSIS, BY REGIONAL - 2017-2028
7.1. KEY FINDINGS
7.2. NORTH AMERICA
7.3. EUROPE
7.4. ASIA PACIFIC
7.5. SOUTH AMERICA
7.6. MIDDLE EAST & AFRICA
8. NORTH AMERICA HEALTHCARE EDI MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
8.1. BY COUNTRY
8.1.1. U.S.
8.1.2. CANADA
8.1.3. MEXICO
9. EUROPE HEALTHCARE EDI MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
9.1. BY COUNTRY
9.1.1. GERMANY
9.1.2. U.K.
9.1.3. FRANCE
9.1.4. ITALY
9.1.5. SPAIN
9.1.6. SWEDEN
9.1.7. BELGIUM
9.1.8. TURKEY
9.1.9. RUSSIA
9.1.10. POLAND
9.1.11. SWITZERLAND
9.1.12. NETHERLANDS
9.1.13. REST OF EUROPE
10. ASIA PACIFIC HEALTHCARE EDI MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
10.1. BY COUNTRY
10.1.1.1. JAPAN
10.1.1.2. CHINA
10.1.1.3. INDIA
10.1.1.4. AUSTRALIA
10.1.1.5. SOUTH KOREA
10.1.1.6. MALAYSIA
10.1.1.7. INDONESIA
10.1.1.8. VIETNAM
10.1.1.9. NEW ZEALAND
10.1.1.10. PHILIPPINES
10.1.1.11. TAIWAN
10.1.1.12. SINGAPORE
10.1.1.13. REST OF ASIA-PACIFIC
11. SOUTH AMERICA HEALTHCARE EDI MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
11.1. BY COUNTRY
11.1.1.1. BRAZIL
11.1.1.2. ARGENTINA
11.1.1.3. CHILE
11.1.1.4. COLOMBIA
11.1.1.5. REST OF SOUTH AMERICA
12. MIDDLE EAST & AFRICA HEALTHCARE EDI MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
12.1. BY COUNTRY
12.1.1.1. SOUTH AFRICA
12.1.1.2. U.A.E.
12.1.1.3. SAUDI ARABIA
12.1.1.4. REST OF MIDDLE EAST AND AFRICA
13. COMPETITIVE LANDSCAPE
13.1. MARKET SHARE OF KEY PLAYERS IN POWER TOOL MARKET
13.1.1. GLOBAL MARKET SHARE ANALYSIS
13.1.2. NORTH AMERICA MARKET SHARE ANALYSIS
13.1.3. EUROPE MARKET SHARE ANALYSIS
13.1.4. ASIA PACIFIC MARKET SHARE ANALYSIS
13.1.5. SOUTH AMERICA MARKET SHARE ANALYSIS
13.1.6. MIDDLE EAST & AFRICA MARKET SHARE ANALYSIS
13.2. LEADERSHIP MAPPING
13.2.1. VISIONARY PLAYERS
13.2.2. INNOVATORS PLAYERS
13.2.3. DYNAMIC DIFFERENTIATORS
13.2.4. EMERGING COMPANIES
13.3. COMPETITIVE SCENARIO AND TRENDS
13.3.1. MERGERS & ACQUISITIONS
13.3.2. PRODUCT LAUNCHES AND DEVELOPMENTS
13.3.3. PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
13.3.4. EXPANSIONS
14. COMPANY PROFILES
14.1.1. MCKESSON CORPORATION
14.1.1.1. COMPANY OVERVIEW
14.1.1.2. COMPANY SNAPSHOT
14.1.1.3. FINANCIAL ANALYSIS
14.1.1.3.1. REVENUE ANALYSIS
14.1.1.3.2. SALES ANALYSIS
14.1.1.3.3. PRICE ANALYSIS
14.1.1.3.4. MARGIN ANALYSIS
14.1.1.4. GEOGRAPHICAL PRESENCE
14.1.1.4.1. NORTH AMERICA
14.1.1.4.2. EUROPE
14.1.1.4.3. ASIA PACIFIC
14.1.1.4.4. SOUTH AMERICA
14.1.1.4.5. MIDDLE EAST & AFRICA
14.1.1.5. PRODUCT PORTFOLIO
14.1.1.6. SWOT ANALYSIS
14.1.1.7. RECENT DEVELOPMENT
14.1.2. OPTUM
14.1.3. ALLSCRIPTS HEALTHCARE SOLUTIONS INC
14.1.4. ATHENAHEALTH
14.1.5. NEXTGEN HEALTHCARE
14.1.6. COGNIZANT TECHNOLOGY CORPORATION
14.1.7. SSI GROUP
14.1.8. CERNER CORPORATION
14.1.9. COMARCH SA
14.1.10. AXWAY SOFTWARE SA
14.1.11. OPTUMINC
14.1.12. DELL TECHNOLOGIES INC
14.1.13. NEXTGEN HEALTHCARE
14.1.14. SYNNEX CORPORATION
14.1.15. COMARCH
14.1.16. AXWAY SOLUTIONS
14.1.17. PLEXIS HEALTHCARE SYSTEMS
15. STRATEGIC RECOMMENDATIONS
LIST OF TABLE
1. RESEARCH ASSUMPTION
2. COVID-19 IMPACT ON MARKET
3. MAJOR DEVELOPMENTS BY VARIOUS COMPANIES
4. GLOBAL HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
5. GLOBAL SOLUTION HEALTHCARE EDI MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
6. GLOBAL SERVICE HEALTHCARE EDI MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
7. GLOBAL HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
8. GLOBAL ON-PREMISE & CLOUD HEALTHCARE EDI MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
9. GLOBAL MOBILE HEALTHCARE EDI MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
10. GLOBAL HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
11. GLOBAL CLAIMS MANAGEMENT HEALTHCARE EDI MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
12. GLOBAL PAYMENT REMITTANCE HEALTHCARE EDI MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
13. GLOBAL PAYMENTS HEALTHCARE EDI MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
14. GLOBAL HEALTHCARE SUPPLY CHAIN HEALTHCARE EDI MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
15. GLOBAL HEALTHCARE EDI MARKET, BY NORTH AMERICA, 2017–2028 REVENUE (USD MILLION)
16. NORTH AMERICA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
17. NORTH AMERICA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
18. NORTH AMERICA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
19. U.S. HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
20. U.S. HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
21. U.S. HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
22. CANADA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
23. CANADA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
24. CANADA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
25. MEXICO HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
26. MEXICO HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
27. MEXICO HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
28. EUROPE HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
29. EUROPE HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
30. EUROPE HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
31. GERMANY HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
32. GERMANY HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
33. GERMANY HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
34. FRANCE HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
35. FRANCE HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
36. FRANCE HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
37. U.K. HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
38. U.K. HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
39. U.K. HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
40. ITALY HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
41. ITALY HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
42. ITALY HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
43. SPAIN HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
44. SPAIN HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
45. SPAIN HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
46. SWEDEN HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
47. SWEDEN HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
48. SWEDEN HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
49. BELGIUM HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
50. BELGIUM HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
51. BELGIUM HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
52. TURKEY HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
53. TURKEY HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
54. TURKEY HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
55. RUSSIA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
56. RUSSIA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
57. RUSSIA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
58. POLAND HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
59. POLAND HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
60. POLAND HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
61. SWITZERLAND HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
62. SWITZERLAND HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
63. SWITZERLAND HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
64. NETHERLANDS HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
65. NETHERLANDS HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
66. NETHERLANDS HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
67. ASIA PACIFIC HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
68. ASIA PACIFIC HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
69. ASIA PACIFIC HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
70. JAPAN HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
71. JAPAN HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
72. JAPAN HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
73. CHINA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
74. CHINA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
75. CHINA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
76. INDIA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
77. INDIA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
78. INDIA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
79. AUSTRALIA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
80. AUSTRALIA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
81. AUSTRALIA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
82. SOUTH KOREA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
83. SOUTH KOREA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
84. SOUTH KOREA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
85. INDONESIA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
86. INDONESIA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
87. INDONESIA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
88. VIETNAM HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
89. VIETNAM HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
90. VIETNAM HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
91. NEW ZEALAND HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
92. NEW ZEALAND HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
93. NEW ZEALAND HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
94. PHILIPPINES HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
95. PHILIPPINES HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
96. PHILIPPINES HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
97. TAIWAN HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
98. TAIWAN HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
99. TAIWAN HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
100. SINGAPORE HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
101. SINGAPORE HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
102. SINGAPORE HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
103. SOUTH AMERICA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
104. SOUTH AMERICA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
105. SOUTH AMERICA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
106. BRAZIL HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
107. BRAZIL HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
108. BRAZIL HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
109. ARGENTINA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
110. ARGENTINA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
111. ARGENTINA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
112. CHILE HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
113. CHILE HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
114. CHILE HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
115. COLOMBIA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
116. COLOMBIA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
117. COLOMBIA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
118. MIDDLE EAST AND AFRICA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
119. MIDDLE EAST AND AFRICA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
120. MIDDLE EAST AND AFRICA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
121. UAE HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
122. UAE HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
123. UAE HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
124. SOUTH AFRICA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
125. SOUTH AFRICA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
126. SOUTH AFRICA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
127. SAUDI ARABIA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
128. SAUDI ARABIA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
129. SAUDI ARABIA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)
130. REST OF MEA HEALTHCARE EDI MARKET, BY DELIVERY MODE, 2017–2028 REVENUE (USD MILLION)
131. REST OF MEA HEALTHCARE EDI MARKET, BY COMPONENT, 2017–2028 REVENUE (USD MILLION)
132. REST OF MEA HEALTHCARE EDI MARKET, BY TRANSACTION TYPE, 2017–2028 REVENUE (USD MILLION)

LIST OF FIGURE
1. RESEARCH DESIGN
2. SCOPE OF THE STUDY
3. GEOGRAPHIC SCOPE
4. CURRENCY CONSIDERATION
5. YEAR CONSIDERATION
6. MARKET ESTIMATION
7. RESEARCH METHODOLOGY
8. DATA TRIANGULATION
9. COVID-19 IMPACT ON MARKET
10. GLOBAL HEALTHCARE EDI MARKET ATTRACTIVENESS ANALYSIS BY COMPONENT
11. GLOBAL HEALTHCARE EDI MARKET ATTRACTIVENESS ANALYSIS BY DELIVERY MODE
12. GLOBAL HEALTHCARE EDI MARKET ATTRACTIVENESS ANALYSIS BY TRANSACTION TYPE
13. GLOBAL HEALTHCARE EDI MARKET ATTRACTIVENESS ANALYSIS BY REGION
14. GLOBAL HEALTHCARE EDI MARKET ATTRACTIVENESS ANALYSIS BY COUNTRY
15. GLOBAL HEALTHCARE EDI MARKET: DYNAMICS
16. PESTEL ANALYSIS
17. SWOT ANALYSIS
18. GLOBAL HEALTHCARE EDI MARKET ANALYSIS BY REGION
19. GLOBAL HEALTHCARE EDI MARKET ANALYSIS BY COMPONENT
20. GLOBAL HEALTHCARE EDI MARKET ANALYSIS BY DELIVERY MODE
21. GLOBAL HEALTHCARE EDI MARKET ANALYSIS BY TRANSACTION TYPE
22. GLOBAL HEALTHCARE EDI MARKET ANALYSIS BY NORTH AMERICA
23. GLOBAL HEALTHCARE EDI MARKET ANALYSIS BY EUROPE
24. GLOBAL HEALTHCARE EDI MARKET ANALYSIS BY ASIA PACIFIC
25. GLOBAL HEALTHCARE EDI MARKET ANALYSIS BY SOUTH AMERICA
26. GLOBAL HEALTHCARE EDI MARKET ANALYSIS BY MIDDLE EAST & AFRICA
27. GLOBAL HEALTHCARE EDI MARKET SHARE BY COMPANY (2020)
28. NORTH AMERICA HEALTHCARE EDI MARKET SHARE BY COMPANY (2020)
29. EUROPE HEALTHCARE EDI MARKET SHARE BY COMPANY (2020)
30. ASIA PACIFIC HEALTHCARE EDI MARKET SHARE BY COMPANY (2020)
31. SOUTH AMERICA HEALTHCARE EDI MARKET SHARE BY COMPANY (2020)
32. MIDDLE EAST & AFRICA HEALTHCARE EDI MARKET SHARE BY COMPANY (2020)